Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Oceanobacillus iheyensis Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP809851OAB
CSB-EP809851OAB
CSB-BP809851OAB
CSB-MP809851OAB
CSB-EP809851OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP809852OAB
CSB-EP809852OAB
CSB-BP809852OAB
CSB-MP809852OAB
CSB-EP809852OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Histidinol-phosphate aminotransferase 1 (hisC1) CSB-YP809853OAB
CSB-EP809853OAB
CSB-BP809853OAB
CSB-MP809853OAB
CSB-EP809853OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Rhamnulokinase (rhaB) CSB-YP809854OAB
CSB-EP809854OAB
CSB-BP809854OAB
CSB-MP809854OAB
CSB-EP809854OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis UPF0178 protein OB0454 (OB0454) CSB-YP809855OAB
CSB-EP809855OAB
CSB-BP809855OAB
CSB-MP809855OAB
CSB-EP809855OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Lactate utilization protein C (lutC) CSB-YP809856OAB
CSB-EP809856OAB
CSB-BP809856OAB
CSB-MP809856OAB
CSB-EP809856OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Energy-coupling factor transporter ATP-binding protein EcfA 2 (ecfA2) CSB-YP809857OAB
CSB-EP809857OAB
CSB-BP809857OAB
CSB-MP809857OAB
CSB-EP809857OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis 50S ribosomal protein L18 (rplR) CSB-YP809858OAB
CSB-EP809858OAB
CSB-BP809858OAB
CSB-MP809858OAB
CSB-EP809858OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis 30S ribosomal protein S17 (rpsQ) CSB-YP809859OAB
CSB-EP809859OAB
CSB-BP809859OAB
CSB-MP809859OAB
CSB-EP809859OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis 30S ribosomal protein S19 (rpsS) CSB-YP809860OAB
CSB-EP809860OAB
CSB-BP809860OAB
CSB-MP809860OAB
CSB-EP809860OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis DNA-directed RNA polymerase subunit beta' (rpoC), partial CSB-YP809861OAB
CSB-EP809861OAB
CSB-BP809861OAB
CSB-MP809861OAB
CSB-EP809861OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis 50S ribosomal protein L33 1 (rpmG1) CSB-YP809862OAB
CSB-EP809862OAB
CSB-BP809862OAB
CSB-MP809862OAB
CSB-EP809862OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Putative ATP:guanido phosphotransferase OB0092 (OB0092) CSB-YP809863OAB
CSB-EP809863OAB
CSB-BP809863OAB
CSB-MP809863OAB
CSB-EP809863OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis UPF0213 protein OB0043 (OB0043) CSB-YP809864OAB
CSB-EP809864OAB
CSB-BP809864OAB
CSB-MP809864OAB
CSB-EP809864OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma penetrans Membrane protein insertase YidC (yidC), partial CSB-YP809865MLU1
CSB-EP809865MLU1
CSB-BP809865MLU1
CSB-MP809865MLU1
CSB-EP809865MLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma penetrans 50S ribosomal protein L22 (rplV) CSB-YP809866MLU
CSB-EP809866MLU
CSB-BP809866MLU
CSB-MP809866MLU
CSB-EP809866MLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma penetrans 50S ribosomal protein L14 (rplN) CSB-YP809867MLU
CSB-EP809867MLU
CSB-BP809867MLU
CSB-MP809867MLU
CSB-EP809867MLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma penetrans 50S ribosomal protein L18 (rplR) CSB-YP809868MLU
CSB-EP809868MLU
CSB-BP809868MLU
CSB-MP809868MLU
CSB-EP809868MLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma penetrans 30S ribosomal protein S2 (rpsB) CSB-YP809869MLU
CSB-EP809869MLU
CSB-BP809869MLU
CSB-MP809869MLU
CSB-EP809869MLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma penetrans Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP809870MLU
CSB-EP809870MLU
CSB-BP809870MLU
CSB-MP809870MLU
CSB-EP809870MLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>